Menstrual Cycle and Hormonal Contraceptives in Female Athletes: Should Symptoms and Nutrition Matter More than Cycle Phase? A Narrative Review.

Valentina Natalucci, Gioi Spinello, Tatiana Moro, Gaspare Pavei, Gennaro Boccia, Antonio La Torre, Matteo Bonato

Journal: Nutrients 2026;18(7):

PMID: 41978194

Abstract

BACKGROUND

Understanding how endogenous hormonal fluctuations and exogenous hormonal modulation influence exercise-related outcomes in women is essential for developing individualized and evidence-informed training and nutritional strategies. This narrative review summarizes the endocrine physiology of the eumenorrheic menstrual cycle and hormonal contraceptive (HC) use and critically examines their implications for athletic performance, neuromuscular function, injury risk, and metabolic regulation in physically active women.

METHODS

A non-systematic literature search was conducted in PubMed, Scopus, and Web of Science for articles published up to January 2026. Search terms combined menstrual cycle-related, hormonal contraceptive, performance, and metabolic/nutritional keywords, and relevant studies were selected based on their relevance to the scope of this narrative review.

RESULTS

Estradiol and progesterone fluctuations may modulate substrate utilization, connective tissue properties, central fatigue regulation, and symptom expression; however, evidence indicates that performance-related effects across menstrual phases are generally small and inconsistent, reflecting both the modest magnitude of physiological effects and the methodological heterogeneity in menstrual cycle phase classification and verification across studies. Similarly, although HC use suppresses endogenous hormonal variability, current findings do not support consistent benefits for performance, injury prevention, or metabolic outcomes, and responses remain heterogeneous. From a nutritional perspective, the endocrine context may contribute to modest changes in energy expenditure, insulin sensitivity, appetite regulation, inflammation, and recovery-related processes. Importantly, symptom burden-including pain, fatigue, sleep disturbances, gastrointestinal discomfort, and fluid retention-emerges as a practical driver of day-to-day training tolerance.

CONCLUSIONS

We propose an integrative framework in which sex hormones define a physiological context rather than deterministic performance regulators, while nutrition acts as a key modifiable factor influencing metabolic responses, symptom severity, and performance consistency.

Address: Department of Experimental and Clinical Medicine, Università Politecnica delle Marche, 60126 Ancona, Italy.; Department of Pathophysiology and Transplantation, University of Milan, 20133 Milan, Italy.; Department of Biomedical Sciences, University of Padova, 35131 Padova, Italy.; Department of Pathophysiology and Transplantation, University of Milan, 20133 Milan, Italy.; Italian Athletics Federation (FIDAL), 00191 Rome, Italy.; Italian Athletics Federation (FIDAL), 00191 Rome, Italy.; Department of Clinical and Biological Sciences, University of Turin, 10126 Turin, Italy.; Italian Athletics Federation (FIDAL), 00191 Rome, Italy.; Department of Biomedical Sciences for Health, University of Milan, 20122 Milan, Italy.; Department of Biomedical Sciences for Health, University of Milan, 20122 Milan, Italy.; Laboratory of Movement and Sport Sciences (LaMSS), IRCCS Istituto Ortopedico Galeazzi, 20157 Milan, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.